Otonomy Reports Third Quarter 2020 Financial Results and Provides Corporate Update

Back to Jobs

Enrollment completed in Phase 3 clinical trial of OTIVIDEX ®   in Ménière’s disease with results expected in the first quarter of 2021 Positive results reported for Phase 1/2 clinical trial of OTO-313 in tinnitus patients Enrollment completed in Phase 1/2 clinical trial of OTO-413 in hearing loss

Apply Now